Inventor · disambiguated record
Patricia Amouzegh
Also filed as: AMOUZEGH PATRICIA · AMOUZEGH PATRICIA LEONIE
9 granted patents·3 pending applications·147 citations·filing 2004–2021
86Inventor score
Files withBOEHRINGER INGELHEIM INT5HAPLOGEN GMBH3AMGEN INC1APEIRON BIOLOGICS AG1HICKEY EUGENE RICHARD1
Top patents by PatentIndex Score
12 records- 0195US8048899B2Compounds which selectively modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2009·Granted Nov 1, 2011·40 cites·32 claims
- 0294US7504396B2Substituted heterocyclic compounds and methods of useAMGEN INC·Filed 2004·Granted Mar 17, 2009·70 cites·12 claims
- 0392US8362039B2Therapeutic uses of compounds which selectively modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2011·Granted Jan 29, 2013·17 cites·20 claims
- 0491US8349871B2Therapeutic uses of compounds which selectively modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2011·Granted Jan 8, 2013·15 cites·6 claims
- 0577US8546443B2Benzylic oxindole pyrimidinesTREU MATTHIAS·Filed 2011·Granted Oct 1, 2013·5 cites·40 claims
- 0658US2022356148A1Antiviral compoundsHAPLOGEN GMBH·Filed 2021·Application pending·0 cites
- 0750US2010261708A1Diazepane Compounds Which Modulate The CB2 ReceptorBOEHRINGER INGELHEIM INT·Filed 2008·Application pending·0 cites
- 0846US11091428B2Antiviral compoundsHAPLOGEN GMBH·Filed 2017·Granted Aug 17, 2021·0 cites·3 claims
- 0946US2012015988A1Sulfone Compounds Which Modulate The CB2 ReceptorHICKEY EUGENE RICHARD·Filed 2009·Application pending·0 cites
- 1035US10472341B2Bicyclic tetrahydrothiazepine derivatives useful for the treatment of neoplastic and/or infectious diseasesAPEIRON BIOLOGICS AG·Filed 2016·Granted Nov 12, 2019·0 cites·30 claims
- 1135US8383651B2Compounds which selectively modulate the CB2 receptorBOEHRINGER INGELHEIM INT·Filed 2010·Granted Feb 26, 2013·0 cites·6 claims
- 1233US11180479B2Antiviral compoundsHAPLOGEN GMBH·Filed 2018·Granted Nov 23, 2021·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Patricia Amouzegh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →